JoshuaDavidLeeMD

Internal Medicine • New York, NY

Addiction Medicine

Assistant Professor, Population Health, New York University School of Medicine

Join to view full profile

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lee's full profile

Already have an account?

Office
Bellevue Hospital
460 First Ave
New York, NY 10016
Phone+1 212-562-3000

Education & Training

NYU Grossman School of MedicineResidency, Internal Medicine, 1999 - 2003
University of Tennessee Health Science Center College of MedicineClass of 1999

Certifications & Licensure

NY State Medical License 2001 - 2026
American Board of Preventive Medicine Addiction Medicine

Awards, Honors, & Recognition

Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2013-2016

Clinical Trials

Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail Start of enrollment: 2010 May 01
Completed
Phase 3
Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care Start of enrollment: 2014 Jun 01
Completed
Phase 4

Publications & Presentations

PubMed

Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder.
Paul J Christine, Sara Lodi, Heather E Hsu, Benjamin Bovell-Ammon, Shapei Yan
Addiction. 2024-07-01
Jail-based medication for opioid use disorder and patterns of reincarceration and acute care use after release: A sequence analysis.
Sungwoo Lim, Teena Cherian, Monica Katyal, Keith S Goldfeld, Ryan McDonald
Journal of Substance Use and Addiction Treatment. 2024-03-01
2 citations
Misclassification of overdose events in the X:BOT study - Authors' reply.
Joshua D Lee, Edward V Nunes, Paul Van Veldhuisen, Robert Lindblad, John Rotrosen
Lancet. 2023-08-12

Journal Articles

Cost-Effectiveness of Buprenorphine–Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse
Joshua D Lee, John Rotrosen, Edward V Nunes, Annals of Internal Medicine